Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Natrunix in combination with Methotrexate for rheumatoid arthritis, with the study status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Natrunix

Snippet

Sponsor: XBiotech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: NOT_YET_RECRUITING